Buspar was not taken off the market for safety reasons. The FDA has formally determined, more than once, that Buspar (buspirone) was not withdrawn from sale for reasons of safety or effectiveness. The brand-name version was discontinued as a business decision by its manufacturer, Bristol-Myers Squibb, after the patent expired and cheaper generic versions became available. The medication itself, buspirone, is still widely prescribed and available today.
Why the Brand Name Disappeared
When a drug’s patent expires, other companies can manufacture generic versions at a fraction of the cost. That’s exactly what happened with Buspar. Once generic buspirone flooded the market, the brand-name product could no longer compete on price, and Bristol-Myers Squibb stopped manufacturing it. This is a routine event in the pharmaceutical industry and happens with dozens of medications every year.
The FDA addressed this directly in a Federal Register notice, stating it had “independently evaluated relevant literature and data for possible postmarketing adverse events and found no information that would indicate that this product was withdrawn from sale for reasons of safety or effectiveness.” The agency listed Buspar in its “Discontinued Drug Product List,” which specifically covers drugs discontinued for reasons other than safety or effectiveness. The FDA reaffirmed this determination again in 2016 and as recently as 2023 for additional dosage forms.
Buspirone Is Still Available
Generic buspirone is actively prescribed and filled at pharmacies across the United States. It comes in tablet form, with a typical starting dose of 7.5 mg twice daily. Doses can be adjusted up to 60 mg per day depending on how you respond. The FDA’s determination that the brand wasn’t pulled for safety reasons also clears the path for continued approval of generic versions, so there’s no regulatory barrier to getting this medication.
Buspirone is not currently listed on the American Society of Health-System Pharmacists’ drug shortage tracker, meaning supply is generally stable. If your pharmacy has had trouble stocking it, that’s a localized supply issue, not a sign the drug has been recalled or restricted.
What Buspirone Treats and How It Works
Buspirone is prescribed for generalized anxiety disorder. Unlike benzodiazepines (such as Xanax or Ativan), it doesn’t work by sedating you or slowing down brain activity broadly. Instead, it acts on a specific type of serotonin receptor in the brain. By interacting with these receptors, it helps regulate serotonin signaling, which plays a central role in mood and anxiety. Its anti-anxiety effects come primarily from calming overactive serotonin pathways, while it may also have mild antidepressant properties through a related but distinct mechanism.
One important difference from benzodiazepines: buspirone doesn’t kick in immediately. It typically takes one to two weeks of consistent use before you notice a meaningful reduction in anxiety. This gradual onset is part of why some people assume it doesn’t work or has been pulled. It’s simply a slower-acting medication that requires patience.
Why It’s Considered Safer Than Alternatives
Buspirone has a notably clean safety profile compared to other anxiety medications. Benzodiazepines carry well-documented risks of dependence, abuse, and withdrawal symptoms that can be severe. Buspirone appears to lack abuse potential entirely and does not lead to physical dependence or withdrawal symptoms when stopped. This makes it a preferred option for people who need long-term anxiety management or who have a history of substance use.
It also causes less sedation than benzodiazepines, meaning it’s less likely to impair your ability to drive, work, or function normally during the day. Common side effects tend to be mild: dizziness, nausea, and headache are the most frequently reported, and they often improve as your body adjusts to the medication.
Why the Confusion Exists
The idea that Buspar was “taken off the market” likely stems from a few overlapping factors. Patients who were prescribed brand-name Buspar and then couldn’t find it at the pharmacy may have assumed something went wrong with the drug. The word “discontinued” on FDA lists sounds alarming if you don’t realize it refers to the brand name, not the active ingredient. And because buspirone works differently from faster-acting anxiety drugs, some people who didn’t experience quick relief may have assumed the drug was ineffective and later heard it was “pulled.”
None of that reflects the drug’s actual safety record. Buspirone has been FDA-approved since the 1980s, has been through extensive post-marketing surveillance, and remains a first-line treatment option for generalized anxiety disorder. If you’re currently taking generic buspirone or considering it, the discontinuation of the Buspar brand name has no bearing on the medication’s safety, effectiveness, or availability.